PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; no. suppl_2; pp. ii114 - ii115
Main Authors Ostrizkova, L, Petruzelka, L, Hejduk, K, Zdrazilova-Dubska, L, Vocka, M, Brancikova, D, Bencsikova, B, Vyzula, R, Obermannova, R
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.06.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw200.33